Market cap: $983,840,995
Exchange: NAS
Sector: Health Technology
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer?s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.
Company Name
Cassava Sciences Inc
Average Volume (10 days)
1,402,614
Average Volume (30 days)
805,337
Moving Average (50 days)
$21.48
Moving Average (200 days)
$22
Ex-Divided Date
n/a
Dividend Yield
0
P/E Ratio
0
Market Cap
983,840,995
Shares Outstanding
43,245,758
52-Week High Split Adjust Only
32.1
52-Week Low Split Adjust Only
12.32
Employee Count
29
Beta
0
Next Earnings Date
2024-05-01
TTM Dividend Rate Per Share
0
Past 5 days
0.07%
Past 30 days
0.1%
Past 3 months
-0.13%
Past 6 months
0.53%
Past year
-0.04%
Past 2 years
-0.16%
Past 5 years
18.78%
Max % Change
-0.37%
| Name | Ticker | Price/Sales (ttm) | Price/Book (ttm) | Forward P/E | PEG Ratio | EV/Revenue |
|---|---|---|---|---|---|---|
| Cassava Sciences Inc | SAVA | n/a | n/a | 539.2 | n/a | n/a |
| Peer Avg | N/A | n/a | n/a | -13.3 | n/a | n/a |
| Ocular Therapeutix Inc | OCUL | n/a | n/a | -19.1 | n/a | n/a |
| Olema Pharmaceuticals Inc | OLMA | n/a | n/a | -21.2 | n/a | n/a |
| Oncocyte Corporation | OCX | n/a | n/a | -13.1 | n/a | n/a |
| Oragenics Inc. | OGEN | n/a | n/a | n/a | n/a | n/a |